|
1
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tada H, Tsuchiya R, Ichinose Y, Koike T,
Nishizawa N, Nagai K and Kato H: A randomized trial comparing
adjuvant chemotherapy versus surgery alone for completely resected
pN2 non-small cell lung cancer (JCOG9304). Lung Cancer. 43:167–173.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Asano N, Kuno T, Hirose Y, Yamada Y,
Yoshida K, Tomita H, Nakamura Y and Mori H: Preventive effects of a
flavonoid myricitrin on the formation of azoxymethane-induced
prema-lignant lesions in colons of rats. Asian Pac J Cancer Prev.
8:73–76. 2007.PubMed/NCBI
|
|
4
|
Khacha-ananda S, Tragoolpua K,
Chantawannakul P and Tragoolpua Y: Antioxidant and anti-cancer cell
proliferation activity of propolis extracts from two extraction
methods. Asian Pac J Cancer Prev. 14:6991–6995. 2013. View Article : Google Scholar
|
|
5
|
Manu KA, Shanmugam MK, Ramachandran L, et
al: Isorhamnetin augments the anti-tumor effect of capeciatbine
through the negative regulation of NF-κB signaling cascade in
gastric cancer. Cancer Lett. 363:28–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saud SM, Young MR, Jones-Hall YL, Ileva L,
Evbuomwan MO, Wise J, Colburn NH, Kim YS and Bobe G:
Chemopreventive activity of plant flavonoid isorhamnetin in
colorectal cancer is mediated by oncogenic Src and beta-catenin.
Cancer Res. 73:5473–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li C, Yang X, Chen C, Cai S and Hu J:
Isorhamnetin suppresses colon cancer cell growth through the
PI3K-Akt-mTOR pathway. Mol Med Rep. 9:935–940. 2014.PubMed/NCBI
|
|
8
|
Ramachandran L, Manu KA, Shanmugam MK, Li
F, Siveen KS, Vali S, Kapoor S, Abbasi T, Surana R, Smoot DT, et
al: Isorhamnetin inhibits proliferation and invasion and induces
apoptosis through the modulation of peroxisome
proliferator-activated receptor gamma activation pathway in gastric
cancer. J Biol Chem. 287:38028–38040. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fulda S and Debatin KM: Debatin, extrinsic
versus intrinsic apoptosis pathways in anticancer chemotherapy.
Oncogene. 25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao J, Wang SZ, Tang XF, Liu N, Zhao D
and Mao ZY: Analysis of thermochemotherapy-induced apoptosis and
the protein expressions of Bcl-2 and Bax in maxillofacial squamous
cell carcinomas. Med Oncol. 28(Suppl 1): S354–S359. 2011.
View Article : Google Scholar
|
|
11
|
Kim R: Recent advances in understanding
the cell death pathways activated by anticancer therapy. Cancer.
103:1551–1560. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fang K, Chen Z, Liu M, Peng J and Wu P:
Apoptosis and calcifi-cation of vascular endothelial cell under
hyperhomocysteinemia. Med Oncol. 32(403)2015. View Article : Google Scholar
|
|
13
|
Choi KS: Autophagy and cancer. Exp Mol
Med. 44:109–120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu D, Yang Y, Liu Q and Wang J:
Inhibition of autophagy by 3-MA potentiates cisplatin-induced
apoptosis in esophageal squamous cell carcinoma cells. Med Oncol.
28:105–111. 2011. View Article : Google Scholar
|
|
15
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mathew R and White E: Why sick cells
produce tumors: The protective role of autophagy. Autophagy.
3:502–505. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
White E: Deconvoluting the
context-dependent role for autophagy in cancer. Nat Rev Cancer.
12:401–410. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mah LY and Ryan KM: Autophagy and cancer.
Cold Spring Harb Perspect Biol. 4:a0088212012. View Article : Google Scholar
|
|
19
|
Karantza-Wadsworth V and White E: Role of
autophagy in breast cancer. Autophagy. 3:610–613. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maycotte P, Aryal S, Cummings CT, Thorburn
J, Morgan MJ and Thorburn A: Chloroquine sensitizes breast cancer
cells to chemotherapy independent of autophagy. Autophagy.
8:200–212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maclean KH, Dorsey FC, Cleveland JL and
Kastan MB: Targeting lysosomal degradation induces p53-dependent
cell death and prevents cancer in mouse models of lymphomagenesis.
J Clin Invest. 118:79–88. 2008. View
Article : Google Scholar
|
|
22
|
Zhang X, Dong Y, Zeng X, Liang X, Li X,
Tao W, Chen H, Jiang Y, Mei L and Feng SS: The effect of autophagy
inhibitors on drug delivery using biodegradable polymer
nanoparticles in cancer treatment. Biomaterials. 35:1932–1943.
2014. View Article : Google Scholar
|
|
23
|
Gibson UE, Heid CA and Williams PM: A
novel method for real time quantitative RT-PCR. Genome Res.
6:995–1001. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Høyer-Hansen M, Bastholm L, Szyniarowski
P, Campanella M, Szabadkai G, Farkas T, Bianchi K, Fehrenbacher N,
Elling F, Rizzuto R, et al: Control of macroautophagy by calcium,
calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol Cell.
25:193–205. 2013. View Article : Google Scholar
|
|
25
|
Abnosi MH, Solemani Mehranjani M, Momeni
HR, Mahdiyeh Najafabadi M, Barati M and Shojafar E: The induction
of apoptosis and autophagy in rat bone marrow mesenchymal stem
cells following in vitro treatment with p-nonylphenol. IJST A.
3:239–244. 2012.
|
|
26
|
Estavillo GM, Verhertbruggen Y, Scheller
HV, et al: Isolation of the plant cytosolic fraction for proteomic
analysis. Methods Mol Biol. 1072:453–467. 2014. View Article : Google Scholar
|
|
27
|
Kalani K, Agarwal J, Alam S, Khan F, Pal A
and Srivastava SK: In silico and in vivo anti-malarial studies of
18β glycyrrhetinic acid from Glycyrrhiza glabra. PLoS One.
8:e747612013. View Article : Google Scholar
|
|
28
|
Hasenjäger A, Gillissen B, Müller A,
Normand G, Hemmati PG, Schuler M, Dörken B and Daniel PT: Smac
induces cytochrome c release and apoptosis independently from
Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human
carcinoma cells. Oncogene. 23:4523–4535. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suzuki S, Higuchi M, Proske RJ, Oridate N,
Hong WK and Lotan R: Implication of mitochondria-derived reactive
oxygen species, cytochrome C and caspase-3 in N-(4-hydroxyphenyl)
retinamide-induced apoptosis in cervical carcinoma cells. Oncogene.
18:6380–6387. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cuvillier O, Nava VE, Murthy SK, Edsall
LC, Levade T, Milstien S and Spiegel S: Sphingosine generation,
cytochrome c release, and activation of caspase-7 in
doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells.
Cell Death Differ. 8:162–171. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang W, Wang Z and Chen T: Curcumol
induces apoptosis via caspases-independent mitochondrial pathway in
human lung adenocarcinoma ASTC-a-1 cells. Med Oncol. 28:307–314.
2011. View Article : Google Scholar
|
|
32
|
Li XY, Lin YC, Huang WL, Lin W, Wang HB,
Lin WZ and Lin SL: Zoledronic acid inhibits human nasopharyngeal
carcinoma cell proliferation by activating mitochondrial apoptotic
pathway. Med Oncol. 29:3374–3380. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mizushima N, Yoshimori T and Levine B:
Methods in mammalian autophagy research. Cell. 140:313–326. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim MS, Jeong EG, Ahn CH, Kim SS, Lee SH
and Yoo NJ: Frameshift mutation of UVRAG, an autophagy-related
gene, in gastric carcinomas with microsatellite instability. Hum
Pathol. 39:1059–1063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hoare M, Young AR and Narita M: Autophagy
in cancer: Having your cake and eating it. Semin Cancer Biol.
21:397–404. 2011.PubMed/NCBI
|
|
36
|
Liu F, Liu D, Yang Y and Zhao S: Effect of
autophagy inhibition on chemotherapy-induced apoptosis in A549 lung
cancer cells. Oncol Lett. 5:1261–1265. 2013.PubMed/NCBI
|
|
37
|
Pellegrini P, Strambi A, Zipoli C,
Hägg-Olofsson M, Buoncervello M, Linder S and De Milito A: Acidic
extracellular pH neutralizes the autophagy-inhibiting activity of
chloroquine: Implications for cancer therapies. Autophagy.
10:562–571. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zou Y, Ling YH, Sironi J, Schwartz EL,
Perez-Soler R and Piperdi B: The autophagy inhibitor chloroquine
overcomes the innate resistance of wild-type EGFR non-small-cell
lung cancer cells to erlotinib. J Thorac Oncol. 8:693–702. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lozy F and Karantza V: Autophagy and
cancer cell metabolism. Semin Cell Dev Biol. 23:395–401. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Giuliani CM and Dass CR: Autophagy and
cancer: Taking the 'toxic' out of cytotoxics. J Pharm Pharmacol.
65:777–789. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gewirtz DA: Autophagy and senescence in
cancer therapy. J Cell Physiol. 229:6–9. 2014.
|
|
42
|
He W, Ma X, Yang X, Zhao Y, Qiu J and Hang
H: A role for the arginine methylation of Rad9 in checkpoint
control and cellular sensitivity to DNA damage. Nucleic Acids Res.
39:4719–4727. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
He W, Zhao Y, Zhang C, An L, Hu Z, Liu Y,
Han L, Bi L, Xie Z, Xue P, et al: Rad9 plays an important role in
DNA mismatch repair through physical interaction with MLH1. Nucleic
Acids Res. 36:6406–6417. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Eng CH and Abraham RT: The autophagy
conundrum in cancer: Influence of tumorigenic metabolic
reprogramming. Oncogene. 30:4687–4696. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jain K, Paranandi KS, Sridharan S and Basu
A: Autophagy in breast cancer and its implications for therapy. Am
J Cancer Res. 3:251–265. 2013.PubMed/NCBI
|
|
46
|
Lorin S, Hamaï A, Mehrpour M and Codogno
P: Autophagy regulation and its role in cancer. Semin Cancer Biol.
23:361–379. 2013. View Article : Google Scholar : PubMed/NCBI
|
